Related Experiment Video

Updated: May 1, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Betel chewing and arecoline affects eotaxin-1, asthma and lung function

Tsu-Nai Wang¹, Ming-Shyan Huang², Meng-Chih Lin³

¹Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan; Center of Excellence for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

|March 25, 2014

Summary

Betel nut chewing is linked to asthma. The study suggests arecoline, a betel nut component, may cause asthma by inducing eotaxin-1, a key inflammatory mediator.

Area of Science:

Environmental Health
Pulmonology
Toxicology

Background:

Betel nut use is prevalent globally, yet its association with asthma remains under-investigated.
The specific mechanisms linking betel nut consumption to asthma are not well understood.
This study explores the relationship between betel chewing, asthma, and potential biomarkers.

Purpose of the Study:

To investigate the association between betel chewing and asthma.
To examine the roles of plasma arecoline and eotaxin-1 in this association.
To elucidate the in vitro mechanism of arecoline-induced eotaxin-1 release.

Main Methods:

A case-control study involving 600 asthmatic patients and 1200 controls in Taiwan.
Measurement of plasma arecoline and eotaxin-1 levels.
In vitro experiments to assess arecoline's effect on eotaxin-1 release from fibroblasts.

Main Results:

Betel chewing showed a significant association with asthma (aOR=2.05), independent of confounders.
This association was attenuated after adjusting for eotaxin-1 levels.
Arecoline and eotaxin-1 levels correlated positively; arecoline negatively impacted lung function.
In vitro, arecoline induced eotaxin-1 release in the presence of IL-4 and TNF-alpha.

Conclusions:

Betel chewing is significantly associated with asthma in the studied population.
Arecoline induction of eotaxin-1 presents a plausible causal pathway for betel nut-associated asthma.
Findings highlight the importance of considering betel nut use in asthma management and prevention.

More Related Videos

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

Related Concept Videos

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Drugs Acting on Autonomic Ganglia: Stimulants

Drugs Acting on Autonomic Ganglia: Stimulants

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Articles linked to this work by shared authors, journal, and citation graph.

Effectiveness of conventional antimicrobial agents against carbapenem resistant non-carbapenem β-lactams susceptible Pseudomonas aeruginosa infection in critically ill patients: a multicentre retrospective study.

BMC infectious diseases·2026

Effects of Initial Lactate Levels and 24-h Lactate Clearance on Mortality in Post-Cardiac Arrest Patients: Insights from the Multicenter TIMECARD Registry.

International journal of medical sciences·2026

Immune Microenvironment and Genetic Signatures of End-Stage Renal Disease and Their Association with Sepsis: Insights from Public Transcriptomic Data and a Multicenter Clinical Cohort.

Biomedicines·2026

Development and validation of a risk stratification tool for predicting COPD exacerbations in patients without prior exacerbation history.

BMJ open respiratory research·2026

High Serum IgE is Associated with Risk of Severe Exacerbations Among Non-Eosinophilic Bronchiectasis.

Lung·2026

Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial.

Annals of the American Thoracic Society·2026

See all related articles